A retrospective medical records review of risk factors for the development of respiratory tract secretions (death rattle) in the dying patient.

Published in: Journal of advanced nursing (2018)

Dying patients with a requirement for a high dose of Midazolam have an increased likelihood of developing death rattle.

Keyphrases